resTORbio amends IPO

resTORbio Inc. (Boston, Mass.) amended its proposed IPO on NASDAQ on Jan. 16 and now plans to sell 5.7 million shares at $14-$16. At the $15 midpoint, the company would raise $85 million and be value...